Skip to content

Grace Therapeutics, Inc. (GRCE) Insider Trading -- Recent Executive & Director Transactions

2 insiders reported 27 Form 4 transactions for Grace Therapeutics, Inc. (GRCE) over the past 18 months (most recent 2026-11-18). Recent activity: Opaleye Management Inc. (10% Owner) Buy 15,879 shares, Opaleye Management Inc. (10% Owner) Buy 29,207 shares, Opaleye Management Inc. (10% Owner) Buy 2,974 shares, Opaleye Management Inc. (10% Owner) Buy 10,328 shares, Opaleye Management Inc. (10% Owner) Buy 5,027 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-11-18Opaleye Management Inc.10% OwnerBuy15,879$28,012
2026-11-18Opaleye Management Inc.10% OwnerBuy29,207$50,292
2026-11-18Opaleye Management Inc.10% OwnerBuy2,974$5,131
2026-11-05Opaleye Management Inc.10% OwnerBuy10,328$18,481
2026-11-05Opaleye Management Inc.10% OwnerBuy5,027$9,060
2026-11-05Opaleye Management Inc.10% OwnerBuy3,087$5,478
2026-10-26Opaleye Management Inc.10% OwnerBuy21,390$41,193
2026-10-26Opaleye Management Inc.10% OwnerBuy66,411$117,408
2026-10-21Opaleye Management Inc.10% OwnerBuy4,256$8,001
2026-10-16Opaleye Management Inc.10% OwnerBuy11,233$21,735
2026-10-16Opaleye Management Inc.10% OwnerBuy23,485$45,685
2026-10-16Opaleye Management Inc.10% OwnerBuy36,347$68,758
2026-10-13Opaleye Management Inc.10% OwnerBuy2,077$4,190
2026-10-13Opaleye Management Inc.10% OwnerBuy5,340$10,918
2026-10-13Opaleye Management Inc.10% OwnerBuy7,215$14,574
2026-10-05Opaleye Management Inc.10% OwnerBuy38,796$78,961
2026-10-05Opaleye Management Inc.10% OwnerBuy20,000$41,368
2026-10-05Opaleye Management Inc.10% OwnerBuy1,694$3,490
2026-10-01Opaleye Management Inc.10% OwnerBuy7,849$16,404
2026-10-01Opaleye Management Inc.10% OwnerBuy9,771$20,519
2026-10-01Opaleye Management Inc.10% OwnerBuy5,318$11,168
2026-09-23Opaleye Management Inc.10% OwnerBuy9,771$20,519
2026-09-23Opaleye Management Inc.10% OwnerBuy5,318$11,168
2026-09-10Kohli PrashantChief Executive OfficerBuy100,000$214,000
2026-09-10Opaleye Management Inc.10% OwnerBuy9,393$19,725

Source: SEC Form 4 filings · as of 2026-11-18